Waldencast plc

Waldencast plc

WALDNYSE / NASDAQConsumer DefensiveSmall cap

$0.85+$0.04 (+4.9%)

Last close · Data as of Oct 15, 2026

Market cap
$224.5M
Revenue
$272.1M
Net margin
-84.4%
ROCE
-39.6%

Hidden because the last close is more than three trading days older than the latest prices of its class.

Waldencast plc price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 15 Oct 2026 close.

1M
Stale
3M
Stale
6M
Stale
1Y
Stale
5Y
Stale
  • Hidden because the last close is more than three trading days older than the latest prices of its class.

52-week range

Day change +$0.04 (+4.9%) from $0.81 to $0.85 · Last close Oct 15, 2026

Best weekday to invest, historically

The same weekly amount in WALD, bought on each weekday since 2021.

News & filings

What Waldencast filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernThe company made a net loss of 230 million US dollars in fiscal 2025.

Strengths

No strength stands out for this company on the data on file.

  • Prices are as of 15 Oct 2026; price-based points are paused until newer prices arrive.

Prices to the 15 Oct 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup.

Read moreShow less

Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products. It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers. The company was incorporated in 2020 and is headquartered in London, the United Kingdom.

Sector
Consumer Defensive
Shares outstanding
128.2M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$224.5M
P/B
0.4x
EV / Sales
1.3x
P/S
0.8x
52-week high
$3.08
52-week low
$0.75

Profitability

Operating margin
-23.9%
Net margin
-84.4%
EBITDA margin
-65.4%
ROE
-49.7%
ROCE
-39.6%
ROIC
-30.3%
ROA
-30.8%
Asset turnover
0.36

Growth

Revenue
$272.1M
Revenue growth, 1Y
-0.7%
Net profit growth, 1Y
441.3%
Free cash flow
-$16.5M

Solvency

Current ratio
1.26
Debt / Equity
0.31
Debt / Assets
0.18
CFO / Net profit
0.06
Cash / Market cap
3.9%

Where the revenue went

FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.

LineFY2025
Revenue$272.1M
Cost of revenue$89.0M
Gross profit$183.0M
Operating expenses$248.0M
Selling, general and administrative$248.0M
Operating income-$65.0M
Interest and other-$197.3M
Pretax income-$262.2M
Tax and other-$32.5M
Net income-$229.8M

Revenue and net profit

Revenue fell 0.7% in FY2025; net profit is the dashed line.

Waldencast plc revenue and net profit by fiscal year
Waldencast plc revenue and net profit by fiscal year
DateRevenueNet profit
FY2021$142.5M-$19.6M
FY2023$218.1M-$90.0M
FY2024$273.9M-$42.4M
FY2025$272.1M-$229.7M

Cash flows

FY2025: -$12.8M from operations, -$16.5M free after investment (dashed).

Waldencast plc operating and free cash flow by fiscal year
Waldencast plc operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2021$3.5M$2.2M
FY2023-$29.8M-$31.8M
FY2024-$8.8M-$11.8M
FY2025-$12.8M-$16.5M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$272.1M-0.7%1Y
EBITDA
-$178.0M-721.6%1Y
Net profit
-$229.7M
Cash from operations
-$12.8M
Free cash flow
-$16.5M
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$272.1M-$178.0M-$229.7M-$16.5M-49.7%-0.7%+441.3%

Monthly returns

Month-by-month returns of WALD across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$746.2M
Liabilities$246.1M
Equity$500.1M
Paid-in capital$981.2M
Retained earnings-$519.0M
Minority interest$38.2M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Consumer Defensive companies placed by value, growth and quality; WALD highlighted.

P/E against peers

Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.

EV / Sales, for the companies without earnings

  1. Waldencast plc (this company)1.3x

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
Waldencast plcWALDthis company$224.5M—0.4x-49.7%—
European Wax Center, Inc.EWCZ$319.1M36.8x4.0x11.0%9.9x
Alico, Inc.ALCO$299.8M-2.0x2.9x-143.0%-78.1x
Franklin Covey Co.FC$269.7M87.9x4.0x4.6%15.2x
Forafric Global PLCAFRI$268.3M-18.0x-30.9x171.4%40.6x
Nu Skin Enterprises, Inc.NUS$258.3M1.6x0.3x19.9%1.2x
Limoneira CompanyLMNR$214.9M-13.4x1.3x-9.9%-28.0x
Acme United CorporationACU$168.3M16.5x1.4x8.7%9.2x
BRC Inc.BRCC$149.8M-12.6x3.3x-26.1%-16.7x
Peer median—-0.2x2.2x6.6%5.2x

Year-to-date ROI

WALD since 1 January, against earlier years.

Historical volatility

WALD's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

Waldencast plc operating margin by fiscal year
Waldencast plc operating margin by fiscal year
DateOperating margin
FY2021-1.1%
FY2022—
FY2023-37.6%
FY2024-19.6%
FY2025-23.9%
LineFY2025
Cost of revenueCost Of Revenue$89.0M
Gross profitGross Profit$183.0M
Operating expensesOperating Expense$248.0M
Research and developmentResearch And Development—
Other operating expensesOther Operating Expenses—
Total expensesTotal Expenses$337.0M
Pretax incomePretax Income-$262.2M

Learn while you research

Academy chapters picked for Waldencast plc and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  3. 03 Cyclical vs Defensive StocksConsumer staples behave defensively across the business cycle.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →